Discover
SRNE
Sorrento Therapeutics, Inc.
0.00
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | -84.62% | |
| 1y | -92.45% |
0.01
day range
0.01
0.00
52 week range
0.01
| Open | 0.01 | Prev Close | 0.00 | Low | 0.01 | High | 0.01 | Mkt Cap | 220.51K |
| Vol | 501.68K | Avg Vol | 157.16K | EPS | -0.07 | P/E | N/A | Forward P/E | -0.45 |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 02-20 | 50-d Avg | 0.00 | 200-d Avg | 0.00 | 1yr Est | 13.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-10-04 | 2024-06 | 0 | N/A | N/A | N/A |
| 2024-07-01 | 2024-03 | 0 | N/A | N/A | N/A |
| 2023-02-28 | 2022-12 | -0.19 | N/A | N/A | N/A |
| 2022-11-08 | 2022-09 | -0.25 | -0.2 | 0.05 | 20.00% |
| 2022-08-15 | 2022-06 | -0.23 | -0.31 | -0.08 | -34.78% |
| 2022-05-05 | 2022-03 | 0 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2022-11-02 | Cantor Fitzgerald | Upgrade | Overweight | |
| 2022-03-25 | HC Wainwright & Co. | Upgrade | Buy | |
| 2021-08-09 | HC Wainwright & Co. | Upgrade | Buy | |
| 2021-01-21 | Alliance Global Partners | Upgrade | Buy | |
| 2020-07-31 | HC Wainwright & Co. | Upgrade | Buy | |
| 2020-05-26 | Dawson James | Upgrade | Buy |
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2018-09-12 | ABG MANAGEMENT, LTD. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
| 2021-03-15 | ASGHAR NAJJAM | Chief Financial Officer | 56.97K | Stock Award(Grant) |
| 2018-01-23 | ASIA PACIFIC MEDTECH BVI, LTD. | Beneficial Owner of more than 10% of a Class of Security | 8.62M | Sale |
| 2020-12-15 | FOLLOWWILL DORMAN | Director | 2.13K | Sale |
| 2021-12-26 | JANDA KIM D | Director | 3.00K | Sale |
| 2022-12-20 | JI HENRY H | Chief Executive Officer | 0.00 | Conversion of Exercise of derivative security |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2022-12-30 | State Street Corporation | 50.64M | 15.56M | 10.73% |
| 2022-12-30 | Blackrock Inc. | 39.42M | 12.11M | 8.35% |
| 2022-12-30 | Vanguard Group, Inc. (The) | 29.54M | 9.08M | 6.26% |
| 2022-12-30 | Geode Capital Management, LLC | 8.91M | 2.74M | 1.89% |
| 2022-12-30 | B. Riley Financial, Inc. | 5.22M | 1.60M | 1.11% |
| 2022-12-30 | B. Riley Securities, Inc. | 5.22M | 1.60M | 1.11% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2022-12-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 40.89M | 12.56M | 8.66% |
| 2022-09-29 | Vanguard Total Stock Market Index Fund | 12.84M | 3.95M | 2.72% |
| 2022-12-30 | iShares Russell 2000 ETF | 10.36M | 3.18M | 2.20% |
| 2022-09-29 | Vanguard Extended Market Index Fund | 5.51M | 1.69M | 1.17% |
| 2022-12-30 | Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 4.27M | 1.31M | 0.91% |
| 2022-12-30 | iShares Russell 2000 Value ETF | 4.11M | 1.26M | 0.87% |
Split
| Split | Date |
|---|---|
| 0.04 : 1 | 2013-08-01 |
| 0.1 : 1 | 2008-10-07 |